Skip to main content
. 2025 Jul 25;15(16):8488–8508. doi: 10.7150/thno.114534

Scheme 1.

Scheme 1

Illustration of designing GB4-BPL for targeted delivery of pPTEN and siCXCR2 to EnzR BmCRPC, which could overcome drug resistance, restrain tumor progress and metastasis as well as remold tumor immune-microenvironment.